IP Library Granted Patent US 9,593,160
Granted Patent B2
US 9,593,160 · App. 14/233,553 · Granted Mar 14, 2017

Engineered microbe-targeting molecules and uses thereof

Inventors: Donald E. Ingber (Boston, MA); Michael Super (Lexington, MA); Jeffrey Charles Way (Cambridge, MA); Mark J. Cartwright (West Newton, MA); Julia B. Berthet (Framingham, MA); Dinah R. Super (Lexington, MA); Martin M. Rottman (Cambridge, MA); Alexander Watters (Melrose, MA)
Assignee: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
C07K16/12A61K47/4843A61K47/48369C07K14/42G01N33/54353G01N33/56911G01N33/56916G01N33/56938G01N33/56961C07K2319/33G01N2333/42G01N2333/4724
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,593,160
App. No.
14/233,553
Granted
Mar 14, 2017
Kind
B2
Abstract

Described herein are engineered microbe-targeting or microbe-binding molecules, kits comprising the same and uses thereof. Some particular embodiments of the microbe-targeting or microbe-binding molecules comprise a carbohydrate recognition domain of mannose-binding lectin, or a fragment thereof, linked to a portion of a Fc region. In some embodiments, the microbe-targeting molecules or microbe-binding molecules can be conjugated to a substrate, e.g., a magnetic microbead, forming a microbe-targeting substrate (e.g., a microbe-targeting magnetic microbead). Such microbe-targeting molecules and/or substrates and the kits comprising the same can bind and/or capture of a microbe and/or microbial matter thereof, and can thus be used in various applications, e.g., diagnosis and/or treatment of an infection caused by microbes such as sepsis in a subject or any environmental surface. Microbe-targeting molecules and/or substrates can be regenerated after use by washing with a low pH buffer or buffer in which calcium is insoluble.

Claims (23)

1. A composition comprising:

a. a microbe;

b. a first molecule comprising an unlabeled engineered microbe-targeting molecule which comprises a lectin or carbohydrate-binding portion thereof; and

c. a second, different, molecule comprising a detectable label conjugated to a targeting agent specific for the microbe.

2. The composition of claim 1 , wherein the engineered microbe-targeting molecule is present on a substrate.

3. The composition of claim 1 , wherein the engineered microbe-targeting molecule is covalently linked to a substrate.

4. The composition of claim 1 , wherein the lectin is a C-type lectin.

5. The composition of claim 1 , wherein the lectin is a collectin.

6. The composition of claim 1 , wherein the lectin is mannose-binding lectin.

7. The composition of claim 1 , wherein the unlabeled engineered microbe-targeting molecule comprises a carbohydrate recognition domain of mannose-binding lectin, or a fragment thereof, linked to a portion of a Fc region.

8. The composition of claim 1 , wherein the engineered microbe-targeting molecule comprises a carbohydrate recognition domain and neck region of a mannose-binding lectin fused to the C-terminal of a Fc fragment of human IgG1.

9. The composition of claim 8 , wherein the portion of the Fc region is linked N-terminal of the carbohydrate recognition domain.

10. The composition of claim 1 , wherein the lectin comprises a carbohydrate recognition domain having the sequence of SEQ ID NO: 4 or a fragment thereof.

11. The composition of claim 1 , wherein the lectin comprises a carbohydrate recognition domain having a sequence having at least 90% identity to the sequence of SEQ ID NO: 4.

12. The composition of claim 1 , wherein the detectable label comprises an enzyme.

13. The composition of claim 12 , wherein the enzyme is horseradish peroxidase (HRP).

14. The composition of claim 12 , which further comprises a substrate for the enzyme.

15. The composition of claim 14 , wherein the substrate is TMB (3,3′,5,5′-tetramethylbenzidine).

16. The composition of claim 1 , wherein the targeting agent specific for the microbe comprises an engineered microbe-targeting molecule or an antibody.

17. The composition of claim 1 , wherein the targeting agent specific for the microbe comprises MBL.

18. A kit comprising:

a. a first molecule comprising an unlabeled engineered microbe-targeting molecule which comprises a lectin or carbohydrate-binding portion thereof; and

b. one or more containers containing a second, different molecule comprising a detectable label conjugated to a targeting agent specific for a microbe.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 28, 2014
From: BERTHET, JULIA B.; CARTWRIGHT, MARK J.; INGBER, DONALD E.; ROTTMAN, MARTIN; SUPER, DINAH R.; SUPER, MICHAEL; WATTERS, ALEXANDER L.; WAY, JEFFREY CHARLES
To: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Reel/Frame 032320/0827 →
Continuity (4)
Provisional Application 61508957 · Jul 18, 2011
Provisional Application 61605052 · Feb 29, 2012
Provisional Application 61605081 · Feb 29, 2012
Related Publication 20140227723A1 · Aug 14, 2014